Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

被引:95
|
作者
Balducci, Chiara
Pierguidi, Laura
Persichetti, Emanuele
Parnetti, Lucilla
Sbaragli, Michele
Tassi, Carmelo
Orlacchio, Aldo
Calabresi, Paolo
Beccari, Tommaso
Rossi, Aroldo
机构
[1] Univ Perugia, Dipartimento Med Interna, I-06126 Perugia, Italy
[2] Univ Perugia, Neurol Clin, Osped Santa Maria della Misericordia, I-06126 Perugia, Italy
[3] Fdn Santa Lucia, IRCCS, Rome, Italy
[4] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06126 Perugia, Italy
关键词
Parkinson's disease; beta-glucocerebrosidase; alpha-mannosidase; beta-mannosidase; beta-hexosaminidase;
D O I
10.1002/mds.21399
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of beta-glucocerebrosidase and the activities of other lysosomal enzymes, alpha-mannosidase, beta-mannosidase, beta-hexosaminidase, and beta-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of alpha-mannosidase, beta-mannosidase, beta-glueocerebrosidase, and beta-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of beta-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases. (c) 2007 Movement Disorder Society.
引用
收藏
页码:1481 / 1484
页数:4
相关论文
共 50 条
  • [1] Cerebrospinal fluid lysosomal enzymes and cognition in Parkinson's disease
    Delgado-Alvarado, M.
    Gago, B.
    Gorostidi, A.
    Jimenez-Urbieta, H.
    Martinez-Lage, P.
    Izagirre, A.
    Paciotti, S.
    Parnetti, L.
    Calabresi, P.
    Beccari, T.
    Rodriguez-Oroz, M.
    MOVEMENT DISORDERS, 2017, 32
  • [2] Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
    Parnetti, Lucilla
    Chiasserini, Davide
    Persichetti, Emanuele
    Eusebi, Paolo
    Varghese, Shiji
    Qureshi, Mohammad M.
    Dardis, Andrea
    Deganuto, Marta
    De Carlo, Claudia
    Castrioto, Anna
    Balducci, Chiara
    Paciotti, Silvia
    Tambasco, Nicola
    Bembi, Bruno
    Bonanni, Laura
    Onofrj, Marco
    Rossi, Aroldo
    Beccari, Tommaso
    El-Agnaf, Omar
    Calabresi, Paolo
    MOVEMENT DISORDERS, 2014, 29 (08) : 1019 - 1027
  • [3] Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects
    Maarouf, Chera L.
    Beach, Thomas G.
    Adler, Charles H.
    Shill, Holly A.
    Sabbagh, Marwan N.
    Wu, Terence
    Walker, Douglas G.
    Kokjohn, Tyler A.
    Roher, Alex E.
    NEUROLOGICAL RESEARCH, 2012, 34 (07) : 669 - 676
  • [4] Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
    Borghi, R
    Marchese, R
    Negro, A
    Marinelli, L
    Forloni, G
    Zaccheo, D
    Abbruzzese, G
    Tabaton, M
    NEUROSCIENCE LETTERS, 2000, 287 (01) : 65 - 67
  • [5] Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
    Tokuda, Takahiko
    Salem, Sultan A.
    Allsop, David
    Mizuno, Toshiki
    Nakagawa, Masanori
    Qureshi, Mohamed M.
    Locascio, Joseph J.
    Schlossmacher, Michael G.
    El-Agnaf, Omar M. A.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (01) : 162 - 166
  • [6] Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease
    Bartl, Michael
    Nilsson, Johanna
    Dakna, Mohammed
    Weber, Sandrina
    Schade, Sebastian
    Xylaki, Mary
    Gomes, Barbara Fernandes
    Ernst, Marielle
    Muntean, Maria-Lucia
    Sixel-Doering, Friederike
    Trenkwalder, Claudia
    Zetterberg, Henrik
    Brinkmalm, Ann
    Mollenhauer, Brit
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [7] A FOLLOW-UP-STUDY OF LYSOSOMAL HYDROLASES IN CEREBROSPINAL-FLUID
    KILPELAINEN, H
    HALONEN, T
    PITKANEN, A
    RIEKKINEN, PJ
    ACTA NEUROLOGICA SCANDINAVICA, 1982, 65 : 272 - 272
  • [8] Cerebrospinal fluid markers of neurodegeneration in Parkinson's disease
    Vranova, H.
    Nevrly, M.
    Mares, J.
    Kanovsky, P.
    Stejskal, D.
    MOVEMENT DISORDERS, 2009, 24 : S285 - S286
  • [9] Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
    Willkommen, Desiree
    Lucio, Marianna
    Moritz, Franco
    Forcisi, Sara
    Kanawati, Basem
    Smirnov, Kirill S.
    Schroeter, Michael
    Sigaroudi, Ali
    Schmitt-Kopplin, Philippe
    Michalke, Bernhard
    PLOS ONE, 2018, 13 (12):
  • [10] Cerebrospinal fluid biomarker for Parkinson's disease: An overview
    Maass, Fabian
    Schulz, Isabel
    Lingor, Paul
    Mollenhauer, Brit
    Baehr, Mathias
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 97 : 60 - 66